Market revenue in 2023 | USD 142.2 million |
Market revenue in 2030 | USD 332.0 million |
Growth rate | 12.9% (CAGR from 2023 to 2030) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Sacral Nerve Stimulator |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Key market players worldwide | Medtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp |
Spinal cord stimulator was the largest segment with a revenue share of 49.65% in 2023. Horizon Databook has segmented the Italy neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
Life expectancy in Italy is among the highest in Europe. Under tight budget constraints, the country has managed to expand & reform the national health benefit basket. In addition, the central government intends to foster a recentralization of funding & design a new system for allocating resources among regions to provide the residents with access to this expanded benefit basket. Thus, increase in healthcare funding has resulted in the rising demand for neurostimulation devices.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account